Literature DB >> 2393029

The ethics of cystic fibrosis carrier screening: where do we stand?

M De Braekeleer, M J Mélançon.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction; Health Care and Public Health

Mesh：

Year:  1990        PMID： 2393029      PMCID： PMC1683850     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  2 in total

1.  The American Society of Human Genetics statement on cystic fibrosis screening.

Authors:  C T Caskey; M M Kaback; A L Beaudet
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

2.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728
  2 in total
  5 in total

1.  Ethics of a genetic program for myotonic dystrophy.

Authors:  C M Laberge
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Cystic fibrosis heterozygote screening in 5,161 pregnant women.

Authors:  D R Witt; C Schaefer; P Hallam; S Wi; B Blumberg; A Fishbach; J Holtzman; S Kornfeld; R Lee; L Nemzer; R Palmer
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

4.  Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.

Authors:  G R Cutting; S M Curristin; E Nash; B J Rosenstein; I Lerer; D Abeliovich; A Hill; C Graham
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

5.  Perception of carrier status by cystic fibrosis siblings.

Authors:  J H Fanos; J P Johnson
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.